NATIONAL OPIOID USE DISORDER GUIDELINE

 

CRISM developed the first Canadian guideline for managing opioid use disorders. The guideline lays out the optimal strategies for the treatment of opioid addiction and recommends opioid agonist treatment with buprenorphine-naloxone as the preferred first-line treatment.

                                                        GUIDELINE (English)                                                                  GUIDELINE (French)

                                        RECOMMENDATIONS AT A GLANCE                                    RECOMMENDATIONS CLINIQUES    

A synopsis of the guideline was published in the Canadian Medical Association Journal (March 5, 2018). You can access it here​, or download the PDF.

CMAJ also produced a podcast, which you can listen to here.

SUPPLEMENTAL MATERIALS: